Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Operating activities:
Net loss	$ (1,874,097)	$ (1,393,226)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	1,286,052	1,144,107
Gain on litigation settlement - discontinued operations		(256,424)
Litigation settlements in common stock		249,800
Deferred compensation		372,100
Stock based compensation	195,419	175,437
Change in operating assets and liabilities:
Restricted cash	(176)	(340,478)
Accounts receivable	2,220,953	(336,040)
Prepaid expenses and other current assets	215,619	97,742
Accounts payable	141,161	319,004
Deferred revenue	(833)	(15,138)
Other accrued expenses and current liabilities	(1,309,141)	321,588
Net cash (used in) provided by operating activities from continuing operations	874,957	338,472
Net cash used in operating activities from discontinued operations	(60,000)
Net cash (used in) provided by operating activities	814,957	338,472
Investing activities:
Purchases of equipment and capitalized development costs	(131,815)	(47,792)
Net cash received from merger with Vertro, Inc., net of merger costs	2,439,360
Purchase of names database and bundled downloads	(707,400)	(917,227)
Net cash used in investing activities	1,600,145	(965,019)
Financing activities:
Advances from term note payable	5,000,000
Deposit to collateralize letter of credit	(475,000)	(475,000)
Advances from credit note payable		6,302,744
Payments on credit note payable and capital leases	3,459,246	3,507,617
Net cash provided by (used in) financing activities	1,065,754	2,320,127
Accumulated other comprehensive income	5,156
Net change - cash	3,486,012	1,693,580
Cash, beginning of year	4,413	118,561
Cash, end of year	3,490,425	1,812,141
Supplemental information:
Interest paid	66,386	185,208
Non-cash investing activities:
Issuance of stock as settlement of deferred compensation	$ 915,750